Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Grand Pharmaceutical Group Limited ( (HK:0512) ) just unveiled an announcement.
Grand Pharmaceutical Group Limited has entered into a Business Collaboration Agreement with the Sirtex Group to jointly develop new radiopaque pharmaceutical products. This collaboration aims to leverage both companies’ expertise and resources, potentially enhancing their global presence and market opportunities by sharing R&D capabilities, resources, and technical knowledge.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company collaborates with the Sirtex Group, known for its SIR-Spheres used in treating inoperable liver cancer, and has been distributing these products in China since 2022.
Average Trading Volume: 33,150,132
Technical Sentiment Signal: Buy
Current Market Cap: HK$33.15B
For detailed information about 0512 stock, go to TipRanks’ Stock Analysis page.